U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
PRALUZATAMAB RAVTANSINE
INN   USAN  
Official Name English
PRALUZATAMAB RAVTANSINE [USAN]
Common Name English
praluzatamab ravtansine [INN]
Common Name English
Praluzatamab ravtansine [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD166 ANTIGEN (ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE)); HUMANIZED MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV2-5*01 (89%) (IGHD)-IGHJ4*01 (93%)) (10.7.13) (1-121)-HOM
Common Name English
CX-2009
Code English
ANTI-CD166 PROBODY-DRUG CONJUGATE CX-2009
Common Name English
ANTI-CD166-DM4 CX-2009
Common Name English
Code System Code Type Description
CAS
2145115-85-9
Created by admin on Sat Dec 16 17:40:36 GMT 2023 , Edited by admin on Sat Dec 16 17:40:36 GMT 2023
PRIMARY
NCI_THESAURUS
C134697
Created by admin on Sat Dec 16 17:40:36 GMT 2023 , Edited by admin on Sat Dec 16 17:40:36 GMT 2023
PRIMARY
FDA UNII
RD2I59M9FC
Created by admin on Sat Dec 16 17:40:36 GMT 2023 , Edited by admin on Sat Dec 16 17:40:36 GMT 2023
PRIMARY
INN
10939
Created by admin on Sat Dec 16 17:40:36 GMT 2023 , Edited by admin on Sat Dec 16 17:40:36 GMT 2023
PRIMARY
USAN
HI-169
Created by admin on Sat Dec 16 17:40:36 GMT 2023 , Edited by admin on Sat Dec 16 17:40:36 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966